Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clavulanic Acid in Cocaine Use Disorder
NCT04411914Phase 1Completed
- Sponsor
- Temple University
- Start
- Sep 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of clavulanic acid in cocaine use disorder (CUD), sponsored by Temple University. Primary endpoint: Brain Glutamate Concentration in the Anterior Cingulate Cortex at Day 10. Started Sep 2020; status: completed.
02
Drugs
clavulanic acid
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT04411914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411914.